Vetsys Pharmaceutical
Cambodia's agricultural landscape is undergoing a significant transformation. Traditionally dominated by rice production, the Kingdom has seen a 15% annual growth in commercial cattle farming and dairy initiatives. Projects in provinces like Pursat, Takeo, and Kampong Speu are pioneering the modern dairy movement. However, the tropical climate—characterized by high humidity and temperature—presents a unique challenge: a high incidence of Bovine Mastitis.
For Cambodian dairy farmers and livestock cooperatives, access to high-quality Intramammary Infusions is no longer a luxury but a fundamental necessity for economic survival. Untreated mastitis accounts for nearly 20% of yield losses in local herds. As a premier global supplier, we provide Cambodian distributors with the clinical-grade pharmaceuticals required to bridge the gap between traditional farming and modern industrial standards.
Our formulations, specifically those utilizing Cefquinome Sulfate and Amoxicillin with Sulbactam Sodium, are engineered for rapid absorption and prolonged therapeutic effect within the mammary tissue. In the context of Cambodia’s heat-stressed cattle, our infusions are designed with stabilized viscosity to ensure the active ingredients remain effective even under varying storage conditions common in Southeast Asia.
Cefquinome Sulfate (4th Gen Cephalosporin): Offers a broad antibacterial spectrum against Gram-positive and Gram-negative bacteria, including Staphylococcus aureus and E. coli. Its unique molecular structure allows for better penetration of the milk-blood barrier, ensuring that the infection is targeted at its source.
Optimized for tropical climates; remains potent in temperatures up to 30°C without immediate degradation.
Formulated to meet strict international standards for milk withdrawal periods, ensuring Cambodian milk is safe for export.
Precision-engineered syringes for atraumatic insertion, reducing secondary infection risks during administration.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our facility is a powerhouse of production, housing specialized workshops for powders, injections, oral solutions, and our flagship intramammary infusions.
Operating under strict Good Manufacturing Practices (GMP), Vetsys has scaled to achieve annual sales exceeding USD 20 million. Our independent research institute, equipped with five specialized laboratories and a team of world-class scientists, ensures that every product we ship to Cambodia is at the cutting edge of veterinary science.
Quality is our cornerstone. We manage every aspect of the supply chain—from raw material sourcing to final packaging—ensuring reliability and performance that Cambodian veterinarians can trust.








Sourcing from our China-based factory offers unparalleled advantages for Cambodian importers. With the implementation of the Regional Comprehensive Economic Partnership (RCEP), trade barriers have significantly decreased, allowing for faster customs clearance and reduced tariffs for pharmaceutical goods moving from China to Phnom Penh or Sihanoukville.
We understand that entering the Cambodian market requires more than just a product; it requires a partnership. Vetsys provides full documentation support, including COA (Certificate of Analysis), GMP Certification, and stability data required for product registration with Cambodian veterinary authorities.
Our team assists local distributors in navigating the "Inter-Ministerial Circular on Control of Veterinary Medicines," ensuring all intramammary infusions meet the specific bio-equivalence and safety standards mandated by the Cambodian government.
The global trend is shifting towards Selective Dry Cow Therapy (SDCT) and the reduction of antimicrobial resistance (AMR). As Cambodia’s dairy industry matures, we are introducing more targeted treatments that reduce the overall use of antibiotics. Our research into synergistic combinations (like Amoxicillin + Sulbactam) allows for lower dosages with higher efficacy, aligning with the "One Health" global initiative.
Digitalization in herd management is also rising in Cambodia. We support integrated health programs where our treatments are part of a data-driven approach to bovine wellness.
Q: What is the lead time for shipping to Cambodia?
A: Standard orders are processed within 15-20 days, with transit times to Phnom Penh typically taking 7-10 days by land or sea.
Q: Are your products registered for use in Cambodia?
A: We provide the full dossier required for local registration. Many of our active ingredients are already approved under the MAFF guidelines.
Q: Can I request a custom formulation?
A: Yes, our R&D lab can customize concentrations of active ingredients like Cefquinome or Florfenicol to meet specific regional bacterial resistance profiles.
Q: Do you offer training for Cambodian farm managers?
A: We provide comprehensive technical manuals and video guides on proper administration techniques to ensure maximum cure rates.
Our commitment extends beyond these products. We also specialize in Florfenicol Intramammary Infusion Tubes and Mastitis Prevention kits tailored for the specific bacterial strains prevalent in Cambodia's Pursat and Takeo regions. Every batch is tested for potency, sterility, and safety.



Vetsys remains dedicated to improving animal health through continuous innovation and sustainable practices. We are your reliable partner for Cambodia's livestock future.